Published in Hepatitis Weekly, September 29th, 1997
While Famvir has been widely used to treat genital herpes outbreaks, patients can now take Famvir daily to help prevent outbreaks. This indication was based on two double-blind, one-year placebo-controlled studies which showed that patients receiving Famvir 250 mg twice daily had approximately 80 percent fewer recurrences.
The twice-daily dosing was selected based on a four-month dose-ranging study which showed that 90 percent of patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.